low energy on retatrutide Retatrutide: A Multi-Receptor Approach to Weight Management 🚨 Common Mistakes I see

Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ

In addition, some studies on recently marketed GLP-1 RAs such as dulaglutide (AWARD studies), albiglutide (HARMONY studies), and lixisenatide (GetGoal studies) included cardiovascular parameters as a part of their non-primary endpoints (Table 2)

In rare cases, some people experience stomach pain, stomach paralysis, and pancreatitis

Hes expecting China, India, Brazil, Canada, and Turkey to attract the most GLP-1 attention as large countries with higher populations of adults with obesity, though he said theres still a question of which medication will scale the best around the world

Nausea (43%), diarrhea (33%), and vomiting (21%) are the most common, consistent with other GLP-1 medications

Sarcopenia Approximately 40% of the weight reduction associated with GLP-1 RAs is derived from a lean body mass, which raises significant concerns regarding its potential negative impact on skeletal muscle functionality [110]